Actively Recruiting
Registry Study of Proton Radiotherapy in Lymphoma
Led by University Hospital Heidelberg · Updated on 2026-04-29
200
Participants Needed
1
Research Sites
678 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim is to record and document a mediastinal PT and the corresponding follow-up data (effectiveness and side effects). General recommendations for planning and feasibility are made within the framework of this study.
CONDITIONS
Official Title
Registry Study of Proton Radiotherapy in Lymphoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed lymphoma according to WHO
- Patient consent
- Patient age 618 years
- Need for mediastinal radiotherapy with an expected benefit from proton therapy compared to photon radiation
- Ability to give informed consent
You will not qualify if you...
- Age under 18 years
- Patient does not consent to data disclosure
- Patient cancels participation in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Heidelberg
Heidelberg, Germany, 69120
Actively Recruiting
Research Team
L
Laila König, MD
CONTACT
A
Adriane Hommertgen, Phd
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here